TirzTirzepatide
Synthetic 39-residue peptide. Loti Labs supplies it as lyophilized powder in 5 mg, 10 mg, 30 mg and 50 mg vials, for laboratory research.



Aib = α-aminoisobutyric acid (residues 2 and 13). K* = Lys20, whose side chain carries a C20 fatty diacid through a linker. The C-terminal serine is amidated.
Specifications
Reference dataFormula, molecular weight and CAS number are reference values for the compound, not measurements of a specific batch.
- Compound
- Tirzepatide
- Class
- Synthetic 39-residue peptide
- Molecular formula
- C225H348N48O68
- Physical presentation
- Lyophilized powder, sealed vial
- Formats
- 5 mg vial · 10 mg vial · 30 mg vial · 50 mg vial
- Sequence
- Y[Aib]EGTFTSDYSI[Aib]LDKIAQ[Lys(acyl)]AFVQWLIAGGPSSGAPPPS-NH2
Current certificates of analysis
TipMatch the batch number on your vial label to the certificate. Click any certificate to open it full size.
5 mg vial
Batch LL-TZ5-926 tested at >99.9% purity by HPLC-UV/MS. Identity was confirmed by mass spectrometry. No endotoxin was detected.
- Batch
- LL-TZ5-926
- Tested
- Oct 12, 2026
- Laboratory
- Krause Analytical
10 mg vial
Batch LL-TZ10-726 tested at 99.78% purity by RP-HPLC. Identity was found to conform by mass spectrometry. Endotoxin screen: <0.05 EU/mL.
- Batch
- LL-TZ10-726
- Tested
- Jul 27, 2026
- Laboratory
- Bioviridian
30 mg vial
Batch LL-TZ30-726 tested at 99.86% purity by RP-HPLC. Identity was found to conform by mass spectrometry. Endotoxin screen: <0.05 EU/mL.
- Batch
- LL-TZ30-726
- Tested
- Aug 1, 2026
- Laboratory
- Bioviridian
50 mg vial
Batch LL-TZ50-726 tested at 99.86% purity by RP-HPLC. Identity was found to conform by mass spectrometry. Endotoxin screen: <0.05 EU/mL.
- Batch
- LL-TZ50-726
- Tested
- Aug 1, 2026
- Laboratory
- Bioviridian
Batch history
RecordEvery certificate stays on record under its batch number, even after a newer batch arrives.
| Tested | Format | Batch | Purity | Identity | Laboratory | |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | 5 mg vial | LL-TZ5-926 | >99.9% | Confirmed | Krause Analytical | Certificate |
| Aug 1, 2026 | 30 mg vial | LL-TZ30-726 | 99.86% | Conforms | Bioviridian | Certificate |
| Aug 1, 2026 | 50 mg vial | LL-TZ50-726 | 99.86% | Conforms | Bioviridian | Certificate |
| Jul 27, 2026 | 10 mg vial | LL-TZ10-726 | 99.78% | Conforms | Bioviridian | Certificate |
| Jan 8, 2026 | 5 mg vial | LLTZ5126 | 99.36% | Not reported | SR Bio Labs | Certificate |
How every batch is tested
MethodEvery Loti Labs batch goes to an independent, U.S.-based third-party laboratory.
- 1
Sample sent
Samples from the production batch go to the laboratory under the batch number.
- 2
Purity
HPLC separates sample components and can be used to assess chromatographic purity. Determining absolute compound content requires a validated quantitative assay.
- 3
Identity
Mass spectrometry provides evidence supporting compound identity, where reported.
- 4
Archived
The certificate is published and kept for good. Search the archive.
Questions researchers ask
ArchiveEvery certificate we have published is searchable in the COA archive.
What purity is the current Tirz (Tirzepatide) batch?
5 mg vial: batch LL-TZ5-926 tested at >99.9% purity by HPLC-UV/MS on Oct 12, 2026, identity confirmed by mass spectrometry. 10 mg vial: batch LL-TZ10-726 tested at 99.78% purity by RP-HPLC on Jul 27, 2026, identity confirmed by mass spectrometry. 30 mg vial: batch LL-TZ30-726 tested at 99.86% purity by RP-HPLC on Aug 1, 2026, identity confirmed by mass spectrometry. 50 mg vial: batch LL-TZ50-726 tested at 99.86% purity by RP-HPLC on Aug 1, 2026, identity confirmed by mass spectrometry.
What is the molecular formula and weight of Tirz (Tirzepatide)?
Tirz (Tirzepatide) has the sequence Y[Aib]EGTFTSDYSI[Aib]LDKIAQ[Lys(acyl)]AFVQWLIAGGPSSGAPPPS-NH2, molecular formula C225H348N48O68 and a molecular weight of 4813 g/mol, CAS 2023788-19-2.
How do I find the certificate for my vial?
Match the lot number printed on the vial label to the batch column in the history table, or search it in the Loti Labs COA archive. Every certificate is kept permanently under its batch number.
What is Tirz (Tirzepatide) from Loti Labs intended for?
Loti Labs supplies Tirz (Tirzepatide) strictly for laboratory, analytical and research use. It is not for human or veterinary use, and it is not a drug, food or cosmetic.
Further reading on Tirz (Tirzepatide)
- VK2735: Dual GIP/GLP-1 Receptor Agonist Research Profile and Oral Formulation Science
- Pemvidutide Research Profile: Dual GLP-1/Glucagon Agonist Mechanisms in Metabolic & Liver Models
- Orforglipron: The First Oral Non-Peptide GLP-1 Receptor Agonist in Research
- Best Research Peptide Vendors in 2026: Complete Guide After Peptide Sciences Shutdown
- LGD-4033 (Ligandrol) Research Guide: Pharmacokinetics, Uses & 2026 Clinical Data
Related compound profiles
Ordering is open to registered researchers
Sign in or create a free research account to view Tirz (Tirzepatide).
Research use only. This page is provided for laboratory, analytical and research reference. Products are not drugs, foods or cosmetics and are not for human or veterinary use.





